You searched for prescription-drugs | Page 55 of 180

Annual Survey of Medicaid Directors Finds States Continue to Adopt Policies to Respond to the Pandemic and Are Addressing Issues Related to Social Determinants of Health and Health Equity

Oct 27, 2021

News Release

More than 18 months into the COVID-19 pandemic, state Medicaid programs around the country continue to reshape policy in response to the public health emergency and at the same time advance broader initiatives and priorities, including efforts to address the social determinants of health and health equity, finds a new KFF survey. The 21st annual KFF survey of Medicaid directors in states and the District of Columbia highlights policies in place and changes implemented or…

Uninsured Most Likely to Delay or Go Without Care or Prescription Drugs Due to Cost

Dec 20, 2019

Feature

Many uninsured people do not obtain the treatments their health care providers recommend for them because of the cost of care. In 2018, uninsured nonelderly adults were more than three times as likely as adults with private coverage to say that they postponed or did not get a needed prescription drug due to cost.

Potential Costs and Impact of Health Provisions in the Build Back Better Act

Nov 23, 2021

Issue Brief

A summary of 10 of the major health coverage and financing provisions of the current Build Back Better Act, with discussion of the potential implications for people and the federal budget.

Racial and Ethnic Disparities in Access to Medical Advancements and Technologies

Feb 22, 2024

Issue Brief

This brief provides an overview of diversity in clinical trials, disparities in access to novel drug therapies and other treatments, and the implications for health and health care.

FDA’s Approval of Biogen’s New Alzheimer’s Drug Has Huge Cost Implications for Medicare and Beneficiaries

Jun 10, 2021

Issue Brief

The question of what would happen when a new, expensive prescription drug comes to market for a disease like Alzheimer’s that afflicts millions of people has loomed large in discussions over drug prices in the U.S. This brief analyzes the cost implications for Medicare and beneficiaries associated with Biogen's new FDA-approved Alzheimer's drug, which will cost $56,000 per year.

Why Medicare’s Aduhelm Coverage Decision Could Increase Pressure on Officials to Roll Back the Record Part B Premium Increase for 2022

Jan 14, 2022

News Release

In a new Policy Watch, KFF experts explain why Medicare’s preliminary decision to cover a new Alzheimer’s drug only for a limited group of beneficiaries is likely to intensify pressure on officials to reconsider the increase in the Medicare Part B premium for 2022. Earlier this week, CMS issued a preliminary National Coverage Determination that would limit coverage of the new drug, Aduhelm, to beneficiaries with mild cognitive impairment who participate in approved clinical trials…

Two-Thirds of the Public Say the U.S. Should Play a Major Role in Distributing COVID-19 Vaccines Globally, But Not Most Republicans

Jun 3, 2021

News Release

With increased attention to the global need for COVID-19 vaccines and the Biden administration’s announcement today about how it plans to distribute the first portion of the 80 million doses it will share by the end of this month, the latest KFF Health Tracking Poll finds that two-thirds of the public (66%) say that the U.S. should play at least a “major role” in distributing COVID-19 vaccines to other countries, including about a quarter (27%)…

Visualizing Health Policy: US Public’s Perspective on Prescription Drug Costs

Oct 15, 2019

Family Planning and Contraceptive Provision Among Females Enrolled in Medicaid

Feb 17, 2022

Issue Brief

This analysis uses claims data from the Transformed Medicaid Statistical Information System (T-MSIS) to examine family planning and contraceptive service provision among women ages 15-49 continuously enrolled in Medicaid for calendar year 2018.

Visualizing Health Policy: US Public’s Perspective on Prescription Drug Costs

Oct 15, 2019

Feature

US Public’s Opinion of Prescription Drug Costs Download VIEW JAMA INFOGRAPHIC

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

Search

Filter